Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

NCT03709771 · clinicaltrials.gov ↗
TERMINATED
Status
2
Enrollment
OTHER
Sponsor class

Stopped Study terminated due to unmet targeted accrual goals with only 2 subjects accrued out of 80 planned due to COVID-19 and the PI on the grant leaving VUMC in October 2021.

Conditions

Interventions

Sponsor

Vanderbilt University Medical Center